Genus PLC
12 October 2007
For Immediate Release
12 October 2007
Genus plc
(the 'Company')
Notification of proposed AIM de-listing
and
Admission to the Official List
Genus plc, a world leading animal genetics company, is pleased to announce that
its intended move from the London Stock Exchange's AIM market ('AIM') to the
Official List (the 'Admission') will take place on 12 November 2007.
The Company gives notice under rule 41 of the AIM Rules that cancellation of
admission of the Company's shares to trading on AIM will take place
simultaneously with the admission of the Company's shares to trading on the
Official List which is expected to become effective at 8.00 a.m. on 12 November
2007.
The Board determined that Genus' shareholders should be given the opportunity to
consider the proposed move and a resolution to approve the Admission was passed
at the Company's Annual General Meeting held on 16 November 2006. The Company
will shortly be publishing its prospectus in connection with the Admission.
For further information please contact:
Genus plc Tel: 01256 345970
Richard Wood, Chief Executive
Martin Boden, Finance Director
Landsbanki Securities (UK) Limited Tel: 020 7426 9000
Nominated Adviser & Joint Broker
Shaun Dobson
Panmure Gordon Tel: 020 7459 3600
Joint Broker
Mark Lander
Buchanan Communications Tel: 020 7466 5000
Charles Ryland / Suzanne Brocks
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.